Sir,
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We would like to thank Asbeutah, AAA for his interest in our manuscript and meaningful insight.[1](#joa312327-bib-0001){ref-type="ref"}, [2](#joa312327-bib-0002){ref-type="ref"} However even following exclusion of the study by Kay et al from the meta‐analysis (as the study did not report any true infections and the numbers reported were from a predictive model, combining results from other studies) the results and conclusion did not differ.[3](#joa312327-bib-0003){ref-type="ref"} Antibiotic envelope reduced the risk of cardiac implantable electronic device infections (RR: 0.51, CI: 0.37‐0.69, *P* \< .05, *I* ^2^ = 66%, *χ* ^2^ *P* \< .05) (Figure [1](#joa312327-fig-0001){ref-type="fig"}). Further as rightly pointed out, the absorbable envelope group of Kolek et al was not included in the analysis due to the overlap of subjects in the control group.[4](#joa312327-bib-0004){ref-type="ref"} This was to avoid the error of "double counting."[5](#joa312327-bib-0005){ref-type="ref"}
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